Skip to main content
. 2020 May 12;10:138. doi: 10.1038/s41398-020-0819-5

Fig. 2. Inhibition of acid sphingomyelinase (ASM) by fluoxetine (Flx) in BMAT is associated with bone loss.

Fig. 2

a Pathway analysis identified the significantly altered metabolic pathways in BMAT in response to boss loss in ovariectomized (OVX) rabbits. b Fluoxetine treatment leads to the accumulation of total sphingomyelins (SMs) in BMAT of both sham and OVX rabbits. Data were mean ± sem, N = 8 rabbits/group, *P < 0.05 and **P < 0.01. c The significant decrease of total ceramides in BMAT in response to fluoxetine treatment. Data were mean ± sem, N = 8 rabbits/group, *P < 0.05. d Fluoxetine treatment significantly reduces sphingosine-1-phosphate (S1P) content in BMAT in both sham and OVX rabbits. Data were mean ± sem, N = 8 rabbits/group, *P < 0.01. e The reduction of BMD is significantly correlated with the increase of SMs and the decrease of S1P in BMAT in response to fluoxetine. N = 8/group. Spearman correlation was used, and P < 0.05. Total SMs (f), ceramides (g), and S1P (h) in BMAT of OVX-CUMS rats treated with fluoxetine or saline. Data were mean ± sem, N = 8/group and **P < 0.01. i The top 25 metabolites in BMAT correlated with BMD changes in rats. Data were log 2 transformed, and Pearson’s correlation was conducted. j Fluoxetine results in the dramatic decrease of the protein expression of SPHK1, ACER1, and ASM in the BMAT of OVX rabbits. A representative image from three independent blots was shown. GAPDH was used as the loading control. k μCT analysis of the trabecular bone region of right distal femora for ASM knockout (Smpd1−/−) and wild-type mice (20 weeks of age). Scar bars, 350 µm. l Quantification of trabecular bone volume/tissue volume (BV/TV) in wild-type and ASM KO mice. m Trabecular number (Tb. N). n The trabecular spacing (Tb. Sp). Data were mean ± sem, N = 8 mice/group and **P < 0.01.